Tuberculosis (TB) remains one of the top 10 causes of death worldwide. TB is a preventable and curable disease, yet 10.4 million contracted TB and 1.7 million died in 2016 according to the WHO. Our experts review the research that is making a positive impact in the fight against TB.
The articles in this Collection were freely available for a limited time but are now only available to subscribers. You can secure Free Access to future Collections by signing up in our Email Preference Center.
Note: The Annual Review of Public Health is open access, thanks to support provided by the Robert Wood Johnson Foundation.
Tuberculosis (TB) remains one of the top 10 causes of death worldwide. TB is a preventable and curable disease, yet 10.4 million contracted TB and 1.7 million died in 2016 according to the WHO. Our experts review the research that is making a positive impact in the fight against TB.
The articles in this Collection were freely available for a limited time but are now only available to subscribers. You can secure Free Access to future Collections by signing up in our Email Preference Center.
Note: The Annual Review of Public Health is open access, thanks to support provided by the Robert Wood Johnson Foundation.
ScienceOpen disciplines: | Medicine, Infectious disease & Microbiology |
Keywords: | Infectious Disease, Tuberculosis, TB, Drug resistant, Immune response, Genetics, Drug development, Epidemic, TB Drug Target, Pathogen |
DOI: | 10.14293/S2199-1006.1.SOR-MED.CL6YXBM.v1 |